• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev .

作者信息

Monti Sara, Montecucco Carlomaurizio

机构信息

Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy

Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy.

出版信息

Ann Rheum Dis. 2021 Feb;80(2):e17. doi: 10.1136/annrheumdis-2020-217800. Epub 2020 May 20.

DOI:10.1136/annrheumdis-2020-217800
PMID:32434818
Abstract
摘要

相似文献

1
Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev .2019冠状病毒病（COVID-19）患者同时存在的合并症和风湿性疾病。回应：莫伊谢耶夫所著的《COVID-19重症监护病房患者的风湿性疾病》
Ann Rheum Dis. 2021 Feb;80(2):e17. doi: 10.1136/annrheumdis-2020-217800. Epub 2020 May 20.
2
Rheumatic diseases in intensive care unit patients with COVID-19.新型冠状病毒肺炎（COVID-19）重症监护病房患者的风湿性疾病
Ann Rheum Dis. 2021 Feb;80(2):e16. doi: 10.1136/annrheumdis-2020-217676. Epub 2020 May 20.
3
Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie .对于抗疟药物在风湿性疾病患者的新型冠状病毒肺炎治疗中明确作用的界定仍为时过早。回应：谢的“羟氯喹降低风湿性疾病患者感染新型冠状病毒肺炎的风险：神话还是现实？”
Ann Rheum Dis. 2021 Jan;80(1):e7. doi: 10.1136/annrheumdis-2020-217633. Epub 2020 Jun 22.
4
COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.沙特阿拉伯东部省份风湿性疾病患者的 COVID-19 。
J Med Life. 2023 Jun;16(6):873-882. doi: 10.25122/jml-2023-0037.
5
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.风湿性疾病患者 COVID-19 疾病严重程度的决定因素。
Clin Rheumatol. 2020 Sep;39(9):2789-2796. doi: 10.1007/s10067-020-05301-2. Epub 2020 Jul 27.
6
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev .对莫伊谢耶夫所著《羟氯喹/氯喹在预防严重急性呼吸综合征冠状病毒2感染（2019冠状病毒病）方面是否有未来？》的回应
Ann Rheum Dis. 2021 Feb;80(2):e20. doi: 10.1136/annrheumdis-2020-217636. Epub 2020 Apr 28.
7
Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini .风湿性疾病患者中新型冠状病毒肺炎（COVID-19）的患病率：需要等待大型合作研究的结果。对Conticini所著《一大群接受生物和靶向合成抗风湿药物治疗的患者中的COVID-19肺炎》的回应
Ann Rheum Dis. 2021 Feb;80(2):e15. doi: 10.1136/annrheumdis-2020-217738. Epub 2020 May 15.
8
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.COVID-19 住院患者合并慢性炎症和自身免疫性风湿性疾病的临床结局：一项多中心匹配队列研究。
Ann Rheum Dis. 2020 Dec;79(12):1544-1549. doi: 10.1136/annrheumdis-2020-218296. Epub 2020 Aug 12.
9
Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.羟氯喹能保护风湿病患者免受新型冠状病毒肺炎（COVID-19）感染吗？对Heldwein和Calado所著的《羟氯喹能预防新型冠状病毒肺炎（COVID-19）传播吗？》以及Joob和Wiwanitkit所著的《系统性红斑狼疮、羟氯喹与非系统性红斑狼疮的新型冠状病毒肺炎（COVID-19）患者：一则评论》的回应
Ann Rheum Dis. 2020 Jun;79(6):e62. doi: 10.1136/annrheumdis-2020-217524. Epub 2020 Apr 23.
10
What is the true incidence of COVID-19 in patients with rheumatic diseases?风湿性疾病患者中新型冠状病毒肺炎的真实发病率是多少？
Ann Rheum Dis. 2021 Feb;80(2):e18. doi: 10.1136/annrheumdis-2020-217615. Epub 2020 Apr 22.